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1. Introduction 
A peptide of the pituitary pars-intermedia @-cell 
tropin) from genetically obese mice (ob/ob) stimulates 
insulin secretion in vitro [ 1,2]. P-Cell tropin (BCT) 
crossreacts with a COOH terminal ACTH antiserum. 
Experiments have now been carried out in which 
purified samples of BCT prepared by Bio-Gel chro- 
matography [2] have been tested for in vivo stimula- 
tion of insulin release and of lipid synthesis in rats. 
The influence of BCT on lipid synthesis in adipocytes 
has also been investigated. 
The results show a significant rise in plasma 
insulin levels 2 mm following the injection of BCT 
into the jugular vein of rats. A significant increase 
in total lipid synthesis in the subcutaneous tissue of 
rats treated with BCT was demonstrated, 45 min fol- 
lowing an injection of 3Hz0, as measured by ‘H 
incorporation into saponified fatty acids. BCT was 
also shown to stimulate total lipid synthesis in vitro 
in adipocytes incubated for 1 h. 
2. Materials and methods 
Male Sprague Dawley rats bred in this department, 
fed ad libitum (-200 g body wt) were used. 
2.1 . p-Cell tropin 
BCT was prepared from the neurointermediate 
lobes of obese mice (ob/ob) and purified on BioGel 
columns as in [2]. The amounts of BCT were deter- 
mined by radioimmunoassay using a COOH terminal 
ACTH antiserum and synthetic 17-39 ACTH as 
standard [2]. 
2.2. Procedure for in vivo experiments 
Rats were anaesthetized with Hypnorm (Janssen 
Pharmaceut., Crown Chemicals, Kent) and Valium 
(Roche Products, Welwyn Garden City). A cannula 
containing saline and heparin (Pularin, Evans Medical, 
Speke, Liverpool) was introduced into the heart 
through an incision in the right jugular vein. The same 
cannula served for collecting blood samples and for 
injecting saline + 3Hz0 or saline containing BCT + 
3Hz0. Precautions were taken to prevent the mixing 
of blood samples with saline and to ensure that the 
cannula was precisely emptied of blood or test sub- 
stances. After cannulation the animal was left to 
recover for 10 min. Three blood samples of 350 ~1 
were drawn through the cannula into a heparised 
syringe at 5 min intervals. Immediately after the third 
sample had been taken experimental rats were injected 
with 25 ng BCT and 6.25 mCi 3Hz0 (Radiochemical 
Centre, Amersham) in 0.5 ml saline. The control rats 
were injected with 0.5 ml saline and an equivalent 
amount of 3Hz0. Further blood samples were col- 
lected from all the animals at 2,5 ,15,30 and 45 min 
intervals, following the injections. 
Animals were killed after 45 min and samples of 
liver, mesenteric fat and subcutaneous fat were frozen 
on dry ice, to be used for lipid analysis. 
2.3. Analytical techniques for in vivo experiments 
Insulin was measured in aliquots of plasma samples 
by radioimmunoassay [3] and plasma glucose by an 
enzymatic calorimetric method (assay kit from Sigma, 
Dorset). The specific activity of the 3Hz0 in plasma 
collected 45 min after the injection of 3Hz0 was 
determined by liquid scintillation counting. 
The total rate of lipid synthesis in vivo was deter- 
mined by measuring incorporation of 3Hz0 into 
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saponified fatty acids extracted from the tissue 
samples collected and the specific activity of the 
plasma 3Hz0 [4-61. 
2.4. Experimental procedure in vitro 
Adipocytes were prepared from epididymal fat 
pads using the method in [7] with minor modifica- 
tions. Adipocytes (0.7-l X 106) were incubated in 
1 ml Krebs Ringer bicarbonate buffer containing 
1 mg glucose, 4% albumin and 1 mCi 3Hz0. Incuba- 
tions were done in plastic vials at 37’C for 1 h in the 
absence and presence of BCT at concentrations indi- 
cated in the results. 
Adipocyte incubations (500 fi) were saponified 
and the saponified fatty acids extracted. The 3H con- 
tent was determined by liquid scintillation counting 
and lipogenesis calculated by the relative activity in 
the fatty acids and the specific activity of the 3Hz0 
in the incubation medium [8]. 
2.5. Statistics 
The statistical significance of the results was cal- 
culated using Student’s t-test. 
3. Results and discussion 
The results in fig.lA show that BCT rapidly 
increased the plasma insulin levels, reaching a maxi- 
mum in 2 min and falling to values which did not 
differ significantly from basal levels after 5 min. This 
effect was not due to hyperglycaemia as no significant 
change in plasma glucose levels was observed at any 
of the time periods measured. The control rats injected 
with saline showed no significant change in plasma 
insulin or glucose concentrations (fig.lB). 
The possible significance of the pituitary control 
of insulin secretion in obesity has been discussed 
[9,10]. BCT is elevated in the ob/ob mouse [lo] as 
well as in other forms of obesity [9]. Evidence for 
the hormonal nature of BCT has been obtained by 
demonstrating its presence in the plasma of the ob/ob 
mice (Billingham, Beloff-Chain and Cawthorne, 
unpublished) and its in vivo action confirms this con- 
clusion. 
The transitory action of BCT on insulin secretion 
found in this study might suggest hat it is unlikely 
to be of biological significance. However, it has been 
demonstrated in the perfused rat pancreas [lo] that 
BCT not only produces a rapid monophasic stimula- 
Fig.1. Influence of BCT on plasma insulin and glucose con- 
centrations in rats: (A) 0.5 ml saline containing 25 ng BCT; 
(B) 0.5 ml saline (controls). Injections at 0 time. Results are 
the mean of: (A) 7 rats;(B) 6 rats. Vertical bars indicate 
SEM: (----I insulin; (---) glucose. Differences between 
insulin levels at 0 min and 2 min, significant in animals 
treated with BCT p < 0.001. 
tion of insulin release at physiological glucose concen- 
trations, but potentiates the biphasic action of high 
glucose stimulation of insulin secretion. It is therefore 
probable that in animals which are hyperphagic and 
hyperglycaemic (as in obesity) the action of BCT on 
insulin levels could be more prolonged. It is of 
interest that a similar monophasic insulin releasing 
activity has been reported [ 1 l] in vivo by a low Mr 
factor (or factors) in hypothalamic extracts of rats. 
Whether this activity is due to the presence of BCT 
can only be ascertained by further purification of the 
hypothalamic insulin secretagogue. 
BCT increased significantly the incorporation of 
3H from 3H10 into the saponifiable fatty acids of 
subcutaneous fat (fig.2). There appeared to be an 
effect on mesenteric fat but this was not statistically 
significant (0.1 > P > 0.05) due to the large variation 
in the treated animals. There was no action of BCT 
on hepatic fatty acids. 
In view of the transitory nature of the elevated 
circulating insulin under the experimental conditions 
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Fig.2. Influence of BCT in fatty acid synthesis. Rats treated 
as in fgl ; samples for determining “H content of saponifi- 
able fatty acids taken at 45 min: (open bars) rats injected 
with saline (controls); (stippled bars) rats injected with 25 ng 
BCT. Both groups injected with 6.25 mCi ‘H,O at 0 time. 
Results are the mean of 6 rats in each group; vertical bars 
indicate *SEM. Differences between control and treated 
groups significant in subcutaneous fat p < 0.05. 
used, it appeared unlikely that the effect of BCT on 
lipid synthesis was indirectly due to its action on 
insulin secretion. To clarify this point it was decided 
to investigate whether BCT had a direct in vitro 
action on lipid synthesis using an adipocyte prepara- 
tion (table 1): BCT had a marked effect at both con- 
centrations studied. 
That BCT stimulated lipogenesis in adipose tissue 
both in vivo and in vitro suggests that this hormone 
may contribute to obesity both by its lipogenic 
Table 1 
Effect of BCT on the rate of Bpogenesis in isolated rat 
adipocytes 
Incubation Rate of lipogenesis 
medium &mol C, units . lo6 cells-’ . h-r) 
Control 0.81 f 0.13 (10) 
+5 ng BCT/ml 2.63a f 0.60 (13) 
+0.5 ng BCT/ml 1.98a + 0.34 (5) 
a Significantly different from controls p < 0.01 
Results expressed as mean values f SEM (no. expt) 
action as well as through its action on insulin secre- 
tion. The rate of lipogenesis is elevated in the adipose 
tissue of genetically obese mice [5]; this has been 
confirmed in this laboratory with 3-week-old ob/ob 
mice compared with homozygote (+/t) lean mice of 
this age group (Carr and Beloff-Chain, unpublished). 
In earlier work on young ob/ob mice (3-week-old) 
it was suggested that BCT may play a role in the early 
development of obesity before the adipose tissue 
becomes insulin resistant [9], and it was assumed that 
excessive insulin secretion could produce the increased 
lipogenesis. However, it was shown [5] that increased 
lipogenesis occurs in adipose tissue of mice at 3 months 
of age in spite of the fact that in this age group 
insulin resistance in adipose tissue is very marked [ 12, 
131. A hormone such as BCT may be contributing 
to increased lipogenesis in these animals. Investiga- 
tions to establish with greater precision the role of 
BCT in the obesity syndrome are underway. 
Acknowledgement 
We are grateful to the Herbert E. Dunhill Trust 
and the Wellcome Trust for grants which supported 
this work and to the Medical Research Council for a 
Research Studentship to A. W. We thank Dr E. 
Bobbioni for help in setting up the in vivo technique. 
References 
111 
PI 
[31 
[41 
[51 
161 
[71 
181 
191 
/lOI 
illI 
[I21 
1131 
Beloff-Chain, A., Dunmore, S. and Morton, J. (1980) 
FEBS Lett. 117,303-307. 
BeloffChain, A., Morton, J., Dunmore, S., Taylor, G. 
andMorris,H.(1981)Biochem.Soc.Trans.9,522-523. 
Hales, C. N. and Randle, P. J. (1963) Biochem. J. 88, 
137-146. 
Jungas, R. L. (1968) Biochemistry 7,3708-3717. 
Hems, D. A., Rath, E. A. and Verrinder, T. R. (1975) 
Biochem. J. 150,167-173. 
Rath,E. A., Salmon, D. M. W. and Hems, D. A. (1979) 
FEBS Lett. 108, 33-36. 
Rodbell,M. (1964) J. Biol. Chem. 239,375-380. 
Windmueller, H. G. and Spaeth, A. E. (1966) J. Biol. 
Chem. 241,2891-2899. 
BeloffChain, A., Bogdanovic, S. and Cawthome, M. A. 
(1979) J. Endocrin. 81,271-279. 
Dunmore, S. and BeloffChain, A. (1982) J. Endocrinol. 
in press. 
Bobbioni, E. and Jeanrenaud, B. (1981) Abstr. EASD. 
Diabetologia 21,250. 
Abraham, R. R. and Beloff-Chain, A. (1971) Diabetes 
20,522-534. 
Chlouverakis, C. and White, P. A. (1969) Metabolism 
18,998-1006. 
232 
